Topic: Diabetes.
Destination: The JDRF Cures Program strategy for disease-modifying therapies is to develop treatments that prevent, halt, or reverse disease progression by rebalancing the immune system and preserving or regrowing beta cells. This highlights an opportunity to explore the onset of T1D from novel perspectives and disciplines, with the potential to identify previously unidentified targets or strategies for disease modifying therapies.This highlights an opportunity to explore the onset of T1D from novel perspectives and disciplines, with the potential to identify previously unidentified targets or strategies for disease modifying therapies.
Budget: $ 750,000 (includes 10% indirect costs).
Duration: 3 years.
Fill out the form below to receive more information: